Compounds for Alzheimer's disease

US9216966B2 · kind B2 · utility

Assignee

• John Manfredi · US

Inventors

• Andrew Gassman · Salt Lake City, US
• Christine Klein · Ossining, US
• Leena Bhoite · Salt Lake City, US
• John Manfredi · West Chester, US
• Rachel Slade · Salt Lake City, US
• Yevgeniya Klimova · Sandy, US
• Robert J. Halter · Salt Lake City, US
• Ashantai J. Yungai · Salt Lake City, US
• Warren S. Weiner · Salt Lake City, US
• Ruth J. Walton · Bountiful, US
• Jon Adam Willardsen · Sandy, US
• Mark B. Anderson · Salt Lake City, US
• Kenton Zavitz · Salt Lake City, US

Key dates

• Filing date: Mar 13, 2013
• Grant date: Dec 22, 2015
• Expiry date: Mar 13, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07F7/1804
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present disclosure relates to novel indole and tetrahydroindole core compounds useful for the treatment of disorders associated with a defect in vesicular transport (e.g., axonal transport).